Eric Jonasch
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Renal cell carcinoma treatment 213
- Cancer Research 118
- Cancer Genomics and Diagnostics 66
- Cancer, Hypoxia, and Metabolism 53
- Co-authors
- Nizar M. Tannir (147 shared papers)Christopher G. Wood (70 shared papers)Surena F. Matin (71 shared papers)W. Kimryn Rathmell (22 shared papers)Pheroze Tamboli (46 shared papers)Cheryl L. Walker (7 shared papers)José A. Karam (38 shared papers)Paul G. Corn (36 shared papers)
- Journals
- Journal of Clinical Oncology (105 papers)The Journal of Urology (19 papers)Annals of Oncology (17 papers)Clinical Genitourinary Cancer (11 papers)Cancer (10 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Eric Jonasch
305 papers receiving 9.5k citations
Eric Jonasch's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 2.6k
- Pulmonary and Respiratory Medicine 5.1k
- Oncology 2.1k
- Molecular Biology 3.9k
- Immunology 609
Countries citing papers authored by Eric Jonasch
This map shows the geographic impact of Eric Jonasch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Jonasch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Jonasch more than expected).
Fields of papers citing papers by Eric Jonasch
This network shows the impact of papers produced by Eric Jonasch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Jonasch. The network helps show where Eric Jonasch may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Jonasch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 323 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types Hit paper breakdown → | 2021 | 705 |
| 2 | Clear cell renal cell carcinoma ontogeny and mechanisms of lethality Hit paper breakdown → | 2020 | 406 |
| 3 | 2015 | 314 | |
| 4 | 2015 | 271 | |
| 5 | Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial Hit paper breakdown → | 2015 | 271 |
| 6 | 2021 | 205 | |
| 7 | 2016 | 191 | |
| 8 | 2013 | 188 | |
| 9 | 2019 | 186 | |
| 10 | 2009 | 149 | |
| 11 | 2013 | 143 | |
| 12 | 2012 | 131 | |
| 13 | 2014 | 130 | |
| 14 | 2012 | 130 | |
| 15 | 2012 | 129 | |
| 16 | 2008 | 126 | |
| 17 | 2010 | 116 | |
| 18 | 2020 | 115 | |
| 19 | 2011 | 112 | |
| 20 | 2019 | 108 |
About Eric Jonasch
Eric Jonasch is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Oncology and Economics and Econometrics, having authored 323 papers that have together received 9.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (213 papers), Cancer Genomics and Diagnostics (66 papers), Cancer, Hypoxia, and Metabolism (53 papers), Renal and related cancers (51 papers), Economic and Financial Impacts of Cancer (29 papers), Cancer Immunotherapy and Biomarkers (24 papers), Bladder and Urothelial Cancer Treatments (19 papers) and Cancer Diagnosis and Treatment (12 papers). The work is most often cited by research in Cancer Research (2.6k citations), Pulmonary and Respiratory Medicine (5.1k citations), Oncology (2.1k citations), Molecular Biology (3.9k citations) and Immunology (609 citations). Eric Jonasch has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Nizar M. Tannir, Christopher G. Wood, Surena F. Matin, W. Kimryn Rathmell, Pheroze Tamboli, Cheryl L. Walker, José A. Karam, Paul G. Corn, Brian I. Rini and Kanishka Sircar. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Annals of Oncology, Clinical Genitourinary Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.